Horizon Kinetics Asset Management LLC Abb Vie Inc. Transaction History

Horizon Kinetics Asset Management LLC

$6.03 Billion
Q3 2024

A detailed history of Horizon Kinetics Asset Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Horizon Kinetics Asset Management LLC holds 25,845 shares of ABBV stock, worth $4.6 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

25,845

Previous 24,123 7.14%

Holding current value

$4.6 Million

Previous $4.14 Million 23.35%

% of portfolio

0.08%

Previous 0.08%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$163.84 - $199.33 $282,132 - $343,246	1,722 Added 7.14%	25,845 $5.1 Million
Q2 2024 Aug 14, 2024	BUY	$154.79 - $180.76 $16,407 - $19,160	106 Added 0.44%	24,123 $4.14 Million
Q1 2024 May 14, 2024	SELL	$159.82 - $182.1 $3,675 - $4,188	-23 Reduced 0.1%	24,017 $4.37 Million
Q4 2023 Feb 15, 2024	SELL	$137.6 - $154.97 $107,878 - $121,496	-784 Reduced 3.16%	24,040 $3.73 Million
Q3 2023 Nov 14, 2023	SELL	$133.59 - $154.65 $3,339 - $3,866	-25 Reduced 0.1%	24,824 $3.7 Million
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $33,657 - $41,884	-254 Reduced 1.01%	24,849 $3.35 Million
Q1 2023 May 12, 2023	SELL	$144.61 - $166.54 $315,828 - $363,723	-2,184 Reduced 8.0%	25,103 $4 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $35,431 - $40,637	264 Added 0.98%	27,287 $3.66 Million
Q2 2022 Aug 05, 2022	SELL	$137.62 - $174.96 $185,098 - $235,321	-1,345 Reduced 4.74%	27,023 $4.14 Million
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $26,395 - $32,750	-200 Reduced 0.7%	28,368 $4.6 Million
Q3 2021 Nov 15, 2021	SELL	$106.4 - $120.78 $53,200 - $60,390	-500 Reduced 1.72%	28,568 $3.08 Million
Q2 2021 Aug 16, 2021	BUY	$105.21 - $117.21 $6,417 - $7,149	61 Added 0.21%	29,068 $3.27 Million
Q1 2021 May 11, 2021	SELL	$102.3 - $112.62 $125,419 - $138,072	-1,226 Reduced 4.06%	29,007 $3.14 Million
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $212,413 - $286,780	-2,639 Reduced 8.03%	30,233 $3.24 Million
Q3 2020 Nov 16, 2020	BUY	$85.91 - $100.83 $65,377 - $76,731	761 Added 2.37%	32,872 $2.88 Million
Q2 2020 Aug 14, 2020	SELL	$73.37 - $98.18 $76,304 - $102,107	-1,040 Reduced 3.14%	32,111 $3.15 Million
Q1 2020 May 13, 2020	BUY	$64.5 - $97.79 $120,421 - $182,573	1,867 Added 5.97%	33,151 $2.53 Million
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $13,848 - $17,328	192 Added 0.62%	31,284 $2.77 Million
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $27,144 - $32,635	431 Added 1.41%	31,092 $2.35 Million
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $33,375 - $42,661	508 Added 1.68%	30,661 $2.23 Million
Q1 2019 May 15, 2019	BUY	$77.14 - $90.79 $2.33 Million - $2.74 Million	30,153 New	30,153 $2.43 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $315B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Horizon Kinetics Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Horizon Kinetics Asset Management LLC with notifications on news.

Account

Horizon Kinetics Asset Management LLC Abb Vie Inc. Transaction History